Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Launches Prempro DTC Campaign Touting Lowest Treatment Dose

This article was originally published in The Pink Sheet Daily

Executive Summary

The print ad states that hormone therapy is not a "lifelong commitment." This is Wyeth's first full-scale DTC campaign for hormone replacement therapy since the results of the WHI study were released.

You may also be interested in...



Premarin DTC Ads Launch For First Time Since WHI Study

Premarin DTC Ads Launch For First Time Since WHI Study

Prempro Prescriptions On The Rise Thanks To DTC Campaign, Wyeth Says

Company sees a “small but consistent” increase in prescription volume and share for the hormone therapy, VP O’Connor says. Growth could indicate “swinging back of the pendulum” following two-year downturn resulting from the Women’s Health Initiative results.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel